Speaker Details

Amy S. Paller, MD, FAAD

Amy S. Paller, MD, FAAD

SESSIONS

S026 Late-breaking Research: Session 1
Mar 9, 2024 9:00 AM - 12:00 PM Room 20B
S050 Late-Breaking Research: Session 2
Mar 10, 2024 1:00 PM - 4:00 PM Room 20B
S052 Atopic Dermatitis
Mar 10, 2024 1:00 PM - 4:00 PM Room 6B
F118 Psoriasis and Atopic Dermatitis: Advances in Comorbidities and Therapy
Mar 11, 2024 3:30 PM - 5:30 PM Room 6A

HANDOUTS

Login to view handouts

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Apogee BioPharm – Consultant (1099 relationship)(Honoraria); Applied Pharma Research – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); Biomendics LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Mitsubishi Tanabe Pharma Corporation – Consultant (1099 relationship)(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Procter and Gamble – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); Timber Pharmaceuticals – Investigator(Grants/Research Funding); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding);